Neurosurgery Devices Market Report by Product Type (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid Management Devices, and Others), Application, End-User, and Region 2024-2032
세계의 신경외과용 기기(Neurosurgery Devices) 시장 규모는 2023년 116억 달러에 달했습니다. IMARC Group은 향후 시장이 2024년부터 2032년 사이에 10.9%의 CAGR로 추이하며 성장 할 것으로 예상되며, 2032년까지 303억 달러에 달할 것으로 예측했습니다.
신경외과용 기기는 중추 신경계 및 말초 신경계에서 수술 및 다양한 병태를 치료하는 데 사용되는 다양한 도구 및 도구를 의미합니다. 주로 파킨슨병, 알츠하이머병, 우울증, 간질, 외상성 뇌·척수 손상 등 진단, 예방, 치료에 사용됩니다. 일반적으로 사용되는 기기에는 신경 자극 장치, 신경외과 내비게이션 장치, 뇌척수액(CSF) 관리 장치(예: 큐렛, 해부기, 엘리베이터 및 론저)가 있습니다. 이러한 도구는 미세 수술, 디스크 절제술, 측두근 아래 골막을 들어올리고 수술 중 두개골 뼈를 조정하는 데 도움이 됩니다.
세계에서 다양한 신경 질환의 유병률이 증가하는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한, 신경질환 및 기타 의학적 질환에 걸리기 쉬운 노년 인구가 증가하고 있는 것도 시장 성장을 뒷받침하고 있습니다. 또한 신경질환에 대한 효과적인 대체치료의 가용성에 대한 대중의 건강의식과 인식도 높아지고 있으며, 이는 시장 성장에 기여하고 있습니다. 그 결과, 종래의 뇌수술보다 신경내시경수술이 선호되게 되어 왔습니다. 예를 들어, 다양한 신경 자극 기기가 목표로하는 천골 신경에 전기 충동을 보내고 뇌 심부 자극을 수행하는 데 사용됩니다. 또한 유로 우회 기기, 액체 색전 기기, 혈전 회수 기기, 신경혈관 내 스텐트, 풍선 카테터 등 혁신적인 최소 침습(MI) 기기의 개발을 포함한 다양한 기술적 진보가 또 다른 성장 촉진요인으로 작용하고 있습니다. 기타 요인으로는 의료 인프라 개선, 광범위한 R&D 활동 등이 있으며 시장을 더욱 견인할 것으로 예측됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 신경외과용 기기 시장은 지금까지 어떻게 추이했으며, 향후 어떻게 추이해 갈 것인가?
- 주요 지역 시장은 어디인가?
- 세계의 신경외과용 기기 시장에 부여한 COVID-19 영향은?
- 제품 유형별 시장 분석은 무엇인가?
- 용도별 시장 분석은 무엇인가?
- 신경외과용 기기 시장 산업의 밸류체인에서 각 단계란?
- 신경외과용 기기 시장 산업의 주요 촉진요인과 과제란?
- 세계의 신경외과용 기기 시장의 구조와 주요 기업란?
- 신경외과용 기기 시장 산업에서 경쟁 정도란?
목차
제1장 서문
제2장 조사 범위 및 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 신경외과용 기기 시장
- 시장 개요
- 시장 실적
- COVID-19 영향
- 시장 예측
제6장 시장 분석 : 제품 유형별
- 신경 자극 기기
- 신경 개입 기기
- 뇌신경외과 네비게이션 시스템
- 뇌척수액(CSF) 관리 기기
- 기타
제7장 시장 분석 : 용도별
- 척수 자극
- 뇌심부 자극요법
- 신경 내시경 검사
- 시장 동향
- 주요 유형
- 비강 신경 내시경 검사
- 뇌실내 신경 내시경 검사
- 경두개 신경 내시경 검사
- 시장 예측
제8장 시장 분석 : 최종 사용자별
제9장 시장 분석 : 지역별
- 북미
- 아시아 태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 남미
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Abbott Laboratories
- Ackermann Instrumente GmbH
- Adeor Medical AG
- Braun Melsungen AG
- Biotronik
- Boston Scientific Corporation
- DePuy Synthes Inc.
- Integra LifeSciences Corporation
- Johnson&Johnson Services Inc.
- Medtronic Plc
- Nevro Corporation
- Nihon Kohden Corporation
- Penumbra Inc.
- Stryker Corporation
LYJ
The global neurosurgery devices market size reached US$ 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.9% during 2024-2032.
Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson's, Alzheimer's, depression, epilepsy and traumatic brain and spinal cord injury. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators and rongeurs. These tools aid in conducting microsurgeries, discectomies, elevating the periosteum below temporalis muscle and adjusting the skull bone during surgeries.
The increasing prevalence of various neurological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to neurological and other medical ailments, is also providing a boost to the market growth. There is also an increasing health consciousness and awareness among the masses regarding the availability of effective treatment alternatives for neurological disorders, which is contributing to the market growth. Consequently, there is a growing preference for neuroendoscopy surgeries over traditional brain surgeries. For instance, various neurostimulation devices are used to send electrical impulses to the targeted sacral nerves and perform deep brain stimulation. Additionally, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents and balloon catheters, are acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurosurgery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application and end-user.
Breakup by Product Type:
Neurostimulation Devices
Neurointerventional Devices
Neurosurgical Navigation Systems
Cerebral Spinal Fluid (CSF) Management Devices
Others
Breakup by Application:
Spinal Cord Stimulation
Chronic Pain
Failed Back Surgery Syndrome
Ischemia
Deep Brain Stimulation
Parkinson's Disease
Tremor
Depression
Others
Neuroendoscopy
Transnasal Neuroendoscopy
Intraventricular Neuroendoscopy
Transcranial Neuroendoscopy
Breakup by End-User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Medtronic Plc, Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc., Stryker Corporation, etc.
Key Questions Answered in This Report:
- How has the global neurosurgery devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global neurosurgery devices market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global neurosurgery devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurosurgery Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Neurostimulation Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Neurointerventional Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Neurosurgical Navigation Systems
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cerebral Spinal Fluid (CSF) Management Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Spinal Cord Stimulation
- 7.1.1 Market Trends
- 7.1.2 Major Types
- 7.1.2.1 Chronic Pain
- 7.1.2.2 Failed Back Surgery Syndrome
- 7.1.2.3 Ischemia
- 7.1.3 Market Forecast
- 7.2 Deep Brain Stimulation
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Parkinson's Disease
- 7.2.2.2 Tremor
- 7.2.2.3 Depression
- 7.2.2.4 Others
- 7.2.3 Market Forecast
- 7.3 Neuroendoscopy
- 7.3.1 Market Trends
- 7.3.2 Major Types
- 7.3.2.1 Transnasal Neuroendoscopy
- 7.3.2.2 Intraventricular Neuroendoscopy
- 7.3.2.3 Transcranial Neuroendoscopy
- 7.3.3 Market Forecast
8 Market Breakup by End-User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Ackermann Instrumente GmbH
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Adeor Medical AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Braun Melsungen AG
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Biotronik
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Boston Scientific Corporation
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 DePuy Synthes Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Integra LifeSciences Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Johnson & Johnson Services Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Medtronic Plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Nevro Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Nihon Kohden Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Penumbra Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.14 Stryker Corporation
- 14.3.14.1 Company Overview
- 14.3.14.2 Product Portfolio
- 14.3.14.3 Financials
- 14.3.14.4 SWOT Analysis
